Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(3 sites)
United States
Geisinger Medical Center, Danville, Pennsylvania Geisinger Community Medical Center, Scranton, Pennsylvania Geisinger Wyoming Valley, Wilkes-Barre, Pennsylvania